MILLENNIUM MANAGEMENT LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,366,859
+20.0%
232,981
+54.8%
0.00%
+33.3%
Q2 2023$6,136,656
+54784.7%
150,482
-49.8%
0.00%
-50.0%
Q1 2023$11,181
+184.0%
299,990
+165.9%
0.01%
+200.0%
Q4 2022$3,937
-100.0%
112,821
-65.9%
0.00%
-81.8%
Q3 2022$18,492,000
-28.6%
330,442
-34.0%
0.01%
-31.2%
Q2 2022$25,900,000
-35.2%
500,389
-9.1%
0.02%
-23.8%
Q1 2022$39,988,000
+2065.0%
550,266
+3422.6%
0.02%
+2000.0%
Q4 2021$1,847,000
-86.5%
15,621
-84.7%
0.00%
-87.5%
Q3 2021$13,719,000
-75.5%
102,267
-70.4%
0.01%
-76.5%
Q2 2021$56,029,000
+33.4%
346,050
-33.9%
0.03%
+13.3%
Q1 2021$42,007,000
+124.7%
523,426
+52.3%
0.03%
+130.8%
Q4 2020$18,694,000
+102.3%
343,639
-26.1%
0.01%
+18.2%
Q3 2020$9,243,000
+222.3%
464,919
+240.8%
0.01%
+175.0%
Q2 2020$2,868,000
+1056.5%
136,425
+708.4%
0.00%
Q4 2019$248,000
-6.1%
16,875
-14.9%
0.00%
Q3 2019$264,000
-93.1%
19,827
-91.6%
0.00%
-100.0%
Q2 2019$3,847,000
+310.1%
235,017
+327.9%
0.01%
+500.0%
Q1 2019$938,000
+22.0%
54,918
-2.5%
0.00%0.0%
Q4 2018$769,000
+12.6%
56,355
+58.6%
0.00%0.0%
Q4 2017$683,000
+48.8%
35,543
+24.0%
0.00%0.0%
Q2 2017$459,000
+25.8%
28,672
+10.8%
0.00%0.0%
Q1 2017$365,000
-82.4%
25,881
-83.7%
0.00%
-75.0%
Q4 2016$2,079,000
-9.0%
158,551
+18.1%
0.00%0.0%
Q3 2016$2,285,000134,2400.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders